Cargando…
Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
PURPOSE: This was an observational, prospective, single-group, multicentre, international study aimed to describe the clinical response, functional impairment, and quality of life (QoL) of patients suffering from major depressive disorder (MDD) and in treatment with Trazodone Once-A-Day (TzOAD) mono...
Autores principales: | Shrashimirova, Milena, Tyanev, Ivan, Cubała, Wiesław J, Wichniak, Adam, Vodickova-Borzova, Claudia, Ruggieri, Alessandro, Bonelli, Annalisa, Lipone, Paola, Comandini, Alessandro, Cattaneo, Agnese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187683/ https://www.ncbi.nlm.nih.gov/pubmed/37201102 http://dx.doi.org/10.2147/NDT.S399948 |
Ejemplares similares
-
An Observational Pilot Study using a Digital Phenotyping Approach in Patients with Major Depressive Disorder Treated with Trazodone
por: Čermák, Jan, et al.
Publicado: (2023) -
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
por: Oggianu, Laura, et al.
Publicado: (2022) -
Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy and Treated with Gabapentin: A Randomized Controlled Pilot Study
por: Lipone, Paola, et al.
Publicado: (2020) -
Rediscovering Trazodone for the Treatment of Major Depressive Disorder
por: Fagiolini, Andrea, et al.
Publicado: (2012) -
Erratum to: Rediscovering Trazodone for the Treatment of Major Depressive Disorder
por: Fagiolini, Andrea, et al.
Publicado: (2013)